# US 2005/0233422 A1 · Rapid and enzymeless cloning of nucleic acid fragments

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0233422 A1
- Document ID: US20050233422A1
- Status: Published application
- Kind: A1
- Application number: 11/045,686
- Filed: 2005-01-28
- Published: 2005-10-20
- Earliest claimed: 2001-04-17
- Inventors: Xiaowu Liang; Andy Teng; Shizhong Chen; Dongyuan Xia; Philip Felgner
- Web page: https://patentgrep.com/patent/US20050233422A1

## CPC

- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C07K 2319/21: containing a His-tag
- C07K 2319/23: containing a GST-tag
- C07K 2319/42: containing a HA(hemagglutinin)-tag
- C07K 2319/43: containing a FLAG-tag
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A method for cloning a nucleic acid fragment into a vector by flanking the fragment with first and second adapter sequences, and contacting the fragment with the vector having sequences homologous to the first and second adapter sequences under conditions such that the nucleic acid fragment is incorporated into the vector by homologous recombination in vivo in a host cell. Additionally, a method for selecting for a successful transformation of a vector by a nucleic acid insert. Also, systems for cloning a nucleic acid fragment into a vector without at least one of a restriction enzyme, a ligase, a gyrase, a single stranded DNA binding protein, or other DNA modifying enzymes. Further, a kit for cloning a nucleic acid fragment into a vector.

## Claims

### Claim at position 1

1-43. (canceled)

### Claim 44

A system for cloning a nucleic acid fragment into a vector without at least one of a restriction enzyme, a ligase, a gyrase, a topoisomerase, or a single stranded DNA binding protein, the system comprising a nucleic acid fragment flanked by first and second adapter sequences and a vector having sequences homologous to the first and second adapter sequences wherein the nucleic acid fragment is adapted to incorporate into the vector by recombination.

### Claim 45 (depends on 44)

The system of claim 44, wherein the nucleic acid fragment flanked by the first and the second adapter sequences is generated by PCR and without the use of at least one of a restriction enzyme, a ligase, a gyrase, a single stranded DNA binding protein, a topoisomerase, or any other DNA modifying enzyme.

### Claim 46 (depends on 44)

The system of claim 44, wherein the nucleic acid fragment flanked by the first and the second adapter sequences is a transcriptionally active PCR fragment.

### Claim 47 (depends on 44)

The system of claim 44, wherein the recombination comprises homologous recombination.

### Claim 48

A system for cloning a nucleic acid fragment into a bacterium without the use of a restriction enzyme, a ligase, a gyrase, or a single stranded DNA binding protein, the system comprising a nucleic acid fragment flanked by first and second adapter sequences and a bacterium bearing a vector, the vector having sequences homologous to the first and second adapter sequences, wherein the nucleic acid fragment is adapted to incorporate into the vector within the bacterium by recombination.

### Claim 49

A kit for cloning a nucleic acid fragment into a vector comprising reagents for amplification of the nucleic acid fragment, wherein the reagents upon amplification provide for a nucleic acid fragment flanked by first and second adapter sequences, a vector, a competent cell, or a competent cell bearing the vector, and the competent cell is ready to be transformed by electroporation or chemical transformation.

### Claim at position 8

50-74. (canceled)
